USV Private Ltd.

https://virtualconnect.chkdin.com/login/35091054
The much awaited Conference of Endocrine Society of India kick starts from today at Bengaluru in hybrid mode. The conference is an academic event of the best minds in the field.

Diabetes is widely prevalent; the risk of diabetes is now observed even in young adults and rural pockets of India. The situation is alarming and this is a wake-up call for everyone. The only way to take control is . Together we can .

100 years ago, insulin was discovered—today, it is inaccessible for millions.

A century on, World Health Organization (WHO)'s Global Diabetes Compact aims to increase access to treatment and care, and improve outcomes for people with diabetes. Read how in The Lancet Diabetes and Endocrinology. https://hubs.li/H0L8FJv0

Encourage your friends and family to follow COVID Appropriate Behaviours. Do your bit to break the transmission.

Novel drug Imeglimin safe option for controlling blood sugar in Diabetes: Study

Novel drug Imeglimin safe option for controlling blood sugar in Diabetes: Study Japan: Patients with type 2 diabetes (T2D) who received twice-daily 100mg of imeglimin monotherapy showed significant improvements in blood sugar control versus those who received placebo, finds a...

A pan-India teleconsultation and educational platform regarding management of diabetes and endocrine disorders started at 4 centres ( Trivendrum/Rohtak/Bengaluru/Cuttack) in our country in view of current COVID-19 pandemic with combined efforts of Dr Tony Joseph, Dr Suvrit Jain, Dr Adarsh Ks & Dr Anand Kumar, aimed to serve patients and extend our expert opinion to primary care physician and practitioners of other specialities.
We wish a very good health and protection from Corona crisis to you and your family.We hope we can continue this endeavour even after containment of the pandemic.

Thanks & Regards 😊

Team ÁSTA Clinic.

Email: [email protected]

https://www.facebook.com/dranandinastaclinics/

ÁSTA Advanced Diabetes & Endocrine Care4U ÁSTA clinic is an innovative platform aimed for quality teleconsultation and education for patient

In this pharmacoepidemiology study, new statin use was associated with a lower risk of all-cause and CV mortality among US veterans 75 years and older and free of ASCVD at baseline.

Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 and Older This retrospective cohort study uses Veterans Health Administration data on adults free of atherosclerotic cardiovascular disease (ASCVD) to evaluate the association between new statin use and all-cause and cardiovascular mortality, and a composite of ASCVD events (myocardial infarction, ischemic...

"IF SELFLESSNESS IS A VIRTUE... YOU ARE THE EPITOME." Happy Doctor's Day.

Can Corona virus damage beta cell and cause T1D?

Mounting clues suggest the coronavirus might trigger diabetes Evidence from tissue studies and some people with COVID-19 shows that the virus damages insulin-producing cells.

https://advances.sciencemag.org/content/6/24/eaba5320

Noninvasive, wearable, and tunable electromagnetic multisensing system for continuous glucose monitoring, mimicking vasculature anatomy Painless, needle-free, and continuous glucose monitoring sensors are needed to enhance the life quality of diabetic patients. To that extent, we propose a first-of-its-kind, highly sensitive, noninvasive continuous glycemic monitoring wearable multisensor system. The proposed sensors are validated o...

Retraction from The Lancet: "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"

Yesterday, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet: https://hubs.ly/H0r8sVt0